Whitnell & Co’s Bausch Health BHC Stock Holding History

Whitnell & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-536	Closed	-$54K	–	386
2015 Q4	$54K	Buy	536 +500	+1,389%	+$56.2K	0.02%	187
2015 Q3	$6K	Buy	+36	New	+$8.39K	﹤0.01%	284

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Whitnell & Co's BHC Position: Q1 2016 in Review

Whitnell & Co sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 536 shares — an estimated $54K sold.

Whitnell & Co first reported a position in BHC in Q3 2015 and held it in 2 quarters. The position peaked at $54K in Q4 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Whitnell & Co reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Whitnell & Co sold 536 Bausch Health shares in Q1 2016, an estimated $54K.
Whitnell & Co first reported a position in Bausch Health in Q3 2015 and held it in 2 quarters.
Whitnell & Co's Bausch Health position peaked at $54K in Q4 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Whitnell & Co's 13F filing for Q1 2016, filed 28 Apr 2016.